From February 2nd - 5th, the second EASL HCC Summit takes place in Geneva, Switzerland
Latest research results on hepatocellular carcinoma – HCC or liver cancer build the center of issues within this EASL congress . Scientists and physicians from Switzerland and all over Europe come to together to vividly discuss latest insights and recent discoveries on liver cancer and patients suffering from it. As participant and speaker Prof. Dufour will present his topic on „NAFLD as risk factor for Hepatocellular Carcinoma“ and remains available to the audience to answer their questions. Together with other physicians of the University Clinic for Visceral Surgery and Medicine he wants to demonstrate our readiness to fight liver cancer.